Brett S. Abrahams

12.3k total citations · 4 hit papers
31 papers, 5.2k citations indexed

About

Brett S. Abrahams is a scholar working on Genetics, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, Brett S. Abrahams has authored 31 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Genetics, 20 papers in Molecular Biology and 12 papers in Cognitive Neuroscience. Recurrent topics in Brett S. Abrahams's work include Genetics and Neurodevelopmental Disorders (19 papers), Autism Spectrum Disorder Research (11 papers) and Congenital heart defects research (8 papers). Brett S. Abrahams is often cited by papers focused on Genetics and Neurodevelopmental Disorders (19 papers), Autism Spectrum Disorder Research (11 papers) and Congenital heart defects research (8 papers). Brett S. Abrahams collaborates with scholars based in United States, Canada and Netherlands. Brett S. Abrahams's co-authors include Daniel H. Geschwind, Maricela Alarcón, Lisa I. Sonnenblick, Julia V. Perederiy, Edward I. Herman, Hongmei Dong, Elior Peles, Olga Peñagarikano, Anatol Bragin and Kellen D. Winden and has published in prestigious journals such as New England Journal of Medicine, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Brett S. Abrahams

31 papers receiving 5.1k citations

Hit Papers

Advances in autism genetics: on the threshold of a new ne... 2008 2026 2014 2020 2008 2011 2008 2013 400 800 1.2k

Peers

Brett S. Abrahams
Rita M. Cantor United States
Michael L. Cuccaro United States
Susan M. Rivera United States
Cynthia M. Schumann United States
Thomas L. Kemper United States
Linda M. Brzustowicz United States
Mu Yang United States
Courtney A. Miller United States
Edward S. Brodkin United States
Rita M. Cantor United States
Brett S. Abrahams
Citations per year, relative to Brett S. Abrahams Brett S. Abrahams (= 1×) peers Rita M. Cantor

Countries citing papers authored by Brett S. Abrahams

Since Specialization
Citations

This map shows the geographic impact of Brett S. Abrahams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brett S. Abrahams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brett S. Abrahams more than expected).

Fields of papers citing papers by Brett S. Abrahams

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brett S. Abrahams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brett S. Abrahams. The network helps show where Brett S. Abrahams may publish in the future.

Co-authorship network of co-authors of Brett S. Abrahams

This figure shows the co-authorship network connecting the top 25 collaborators of Brett S. Abrahams. A scholar is included among the top collaborators of Brett S. Abrahams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brett S. Abrahams. Brett S. Abrahams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Salamone, Alessia, Gaetano Terrone, Silvia Balosso, et al.. (2022). Cholesterol 24-hydroxylase is a novel pharmacological target for anti-ictogenic and disease modification effects in epilepsy. Neurobiology of Disease. 173. 105835–105835. 14 indexed citations
2.
Cogram, Patricia, et al.. (2019). Gaboxadol Normalizes Behavioral Abnormalities in a Mouse Model of Fragile X Syndrome. Frontiers in Behavioral Neuroscience. 13. 141–141. 34 indexed citations
3.
Kanellopoulos, Alexandros K., et al.. (2019). Domain-Specific Cognitive Impairments in Humans and Flies With Reduced CYFIP1 Dosage. Biological Psychiatry. 86(4). 306–314. 12 indexed citations
4.
Cogram, Patricia, et al.. (2018). Gaboxadol Normalizes Behavioral Abnormalities in a Mouse Model of Fragile X Syndrome (P1.323). Neurology. 90(15_supplement). 1 indexed citations
5.
Ross, Lars A., et al.. (2017). Common variation in the autism risk gene CNTNAP2, brain structural connectivity and multisensory speech integration. Brain and Language. 174. 50–60. 6 indexed citations
6.
Wang, Tao, Tulio Guadalupe, Rebecca A. Nebel, et al.. (2016). A Common CYFIP1 Variant at the 15q11.2 Disease Locus Is Associated with Structural Variation at the Language-Related Left Supramarginal Gyrus. PLoS ONE. 11(6). e0158036–e0158036. 28 indexed citations
7.
Nebel, Rebecca A., Dejian Zhao, Erika Pedrosa, et al.. (2016). Reduced CYFIP1 in Human Neural Progenitors Results in Dysregulation of Schizophrenia and Epilepsy Gene Networks. PLoS ONE. 11(1). e0148039–e0148039. 28 indexed citations
8.
Oguro‐Ando, Asami, Clark Rosensweig, Edward I. Herman, et al.. (2014). Increased CYFIP1 dosage alters cellular and dendritic morphology and dysregulates mTOR. Molecular Psychiatry. 20(9). 1069–1078. 88 indexed citations
9.
Dougherty, Joseph D., Susan E. Maloney, David F. Wozniak, et al.. (2013). The Disruption ofCelf6, a Gene Identified by Translational Profiling of Serotonergic Neurons, Results in Autism-Related Behaviors. Journal of Neuroscience. 33(7). 2732–2753. 70 indexed citations
10.
Abrahams, Brett S., Dan E. Arking, Jerry L. Campbell, et al.. (2013). SFARI Gene 2.0: a community-driven knowledgebase for the autism spectrum disorders (ASDs). Molecular Autism. 4(1). 36–36. 495 indexed citations breakdown →
11.
Peñagarikano, Olga, Brett S. Abrahams, Edward I. Herman, et al.. (2011). Absence of CNTNAP2 Leads to Epilepsy, Neuronal Migration Abnormalities, and Core Autism-Related Deficits. Cell. 147(1). 235–246. 794 indexed citations breakdown →
12.
Abrahams, Brett S., et al.. (2010). Language‐related Cntnap2 gene is differentially expressed in sexually dimorphic song nuclei essential for vocal learning in songbirds. The Journal of Comparative Neurology. 518(11). 1995–2018. 37 indexed citations
13.
Abrahams, Brett S. & Daniel H. Geschwind. (2010). Connecting Genes to Brain in the Autism Spectrum Disorders. Archives of Neurology. 67(4). 395–9. 131 indexed citations
14.
O’Roak, Brian J., Angeliki Louvi, Abha R. Gupta, et al.. (2008). Molecular Cytogenetic Analysis and Resequencing of Contactin Associated Protein-Like 2 in Autism Spectrum Disorders. The American Journal of Human Genetics. 82(1). 165–173. 397 indexed citations
15.
Kumar, Ravinesh A., Kevin A. McGhee, Stephen Leach, et al.. (2008). Initial association of NR2E1 with bipolar disorder and identification of candidate mutations in bipolar disorder, schizophrenia, and aggression through resequencing. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 147B(6). 880–889. 38 indexed citations
16.
Vernes, Sonja C., Dianne F. Newbury, Brett S. Abrahams, et al.. (2008). A Functional Genetic Link between Distinct Developmental Language Disorders. New England Journal of Medicine. 359(22). 2337–2345. 459 indexed citations
17.
Kumar, Revati, Stephen Leach, Russell J. Bonaguro, et al.. (2006). Mutation and evolutionary analyses identify NR2E1‐candidate‐regulatory mutations in humans with severe cortical malformations. Genes Brain & Behavior. 6(6). 503–516. 11 indexed citations
18.
Abrahams, Brett S., et al.. (2005). Pathological Aggression in “Fierce” Mice Corrected by Human Nuclear Receptor 2E1. Journal of Neuroscience. 25(27). 6263–6270. 42 indexed citations
19.
Kumar, Ravinesh A., et al.. (2004). Unexpected embryonic stem (ES) cell mutations represent a concern in gene targeting: Lessons from “fierce” mice. genesis. 38(2). 51–57. 17 indexed citations
20.
Abrahams, Brett S., Melissa L. Berry, Diana Palmquist, et al.. (2002). Novel Vertebrate Genes and Putative Regulatory Elements Identified at Kidney Disease and NR2E1/fierce Loci. Genomics. 80(1). 45–53. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026